{"schema_version":"secwatch.filing_event.v1","accession":"0000009326-25-000019","form_type":"8-K","ticker":"BCPC","cik":"0000009326","company_name":"BALCHEM CORP","filed_at":"2025-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.659971+00:00","generated_at":"2026-05-17T03:10:22.640378+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Balchem Q3 2025: record sales $267.6M, adj. EPS $1.35, all segments grow","bullets":["Record net sales $267.6M (+11.5% YoY); GAAP EPS $1.24 vs $1.03; adjusted EPS $1.35 vs $1.13.","Record adjusted EBITDA $71.4M (+11.0% YoY); free cash flow $50.7M.","All three segments achieved sales and earnings growth; new NY microencapsulation plant to double capacity.","Net debt reduced to $88.9M, leverage 0.3x; repaid $36M on revolver during Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0000009326-25-000019","json":"https://secwatch.observer/filing/0000009326-25-000019.json","markdown":"https://secwatch.observer/filing/0000009326-25-000019.md","text":"https://secwatch.observer/filing/0000009326-25-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/9326/000000932625000019/0000009326-25-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/9326/000000932625000019/bcpc-20251021.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:10:22.640378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}